Top Markets
Coin of the day
Immunotech Biopharm Ltd Immunotech Biopharm Ltd

Immunotech Biopharm Ltd

6978
Helyezés a részvények között #27803
Immunotech Biopharm Ltd operates as a biopharmaceutical firm specializing in... Immunotech Biopharm Ltd operates as a biopharmaceutical firm specializing in cellular immunotherapy. Its primary activities involve the investigation, development, and market introduction of T cell-based immunotherapy solutions for various cancers within the People's Republic of China. The company's flagship product, EAL, is a multi-target cellular immunotherapy currently undergoing Phase II clinical trials for the purpose of preventing liver cancer recurrence after surgery. Furthermore, Immunotech Biopharm is conducting both preclinical and clinical research on EAL for its potential use in treating lung cancer, glioma, gastric cancer, and colorectal cancer. Other pipeline assets include the 6B11-OCIK injection, which is in Phase I trials for ovarian cancer; the CAR-T-19 injection product, targeting B-cell acute lymphoblastic leukaemia; and a range of TCR-T cell products designed for solid tumor treatment. Established in 2006, the company's main office is located in Beijing, China.
Részvényárfolyam
$0.0492516
Piaci kapitalizáció
$30.41M
Változás (1 nap)
1.32%
Változás (1 év)
-91.28%
Ország
CN
Kereskedés Immunotech Biopharm Ltd (6978)

Kategória

Immunotech Biopharm Ltd (6978) osztalékhozamának története
Immunotech Biopharm Ltd (tőzsdei szimbólum: 6978) osztalékhozama (TTM) 2026 állapot szerint: 0
Átlagos osztalékhozam az elmúlt 5 évben: 0.00%
Immunotech Biopharm Ltd (6978) osztalékhozamainak története 2026 és 2026 között
Éves záró osztalékhozam (TTM)
Év Osztalékhozam Változtassa meg
Nincs elég adat a megadott dátumokhoz.
Hasonló cégek vagy versenytársak osztalékhozamai (TTM)
Vállalat Osztalékhozam Ország
0.00%
US
0.00%
US
0.00%
NL
3.12%
AU
0.00%
CH